Bollard Group’s BioLife Solutions BLFS Stock Holding History

Bollard Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-258	Closed	-$6K	–	402
2023 Q2	$6K	Buy	+258	New	+$5.43K	﹤0.01%	361
2022 Q2	–	Sell	-5,545	Closed	-$126K	–	302
2022 Q1	$126K	Hold	5,545	–	–	﹤0.01%	266
2021 Q4	$207K	Hold	5,545	–	–	0.01%	233
2021 Q3	$235K	Hold	5,545	–	–	0.01%	216
2021 Q2	$247K	Hold	5,545	–	–	0.01%	203
2021 Q1	$200K	Hold	5,545	–	–	0.01%	221
2020 Q4	$221K	Hold	5,545	–	–	0.01%	194
2020 Q3	$160K	Hold	5,545	–	–	0.01%	209
2020 Q2	$91K	Buy	+5,545	New	+$76.4K	﹤0.01%	264

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Bollard Group's BLFS Position: Q3 2023 in Review

Bollard Group sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 258 shares — an estimated $6K sold.

Bollard Group first reported a position in BLFS in Q2 2020 and held it in 9 quarters. The position peaked at $247K in Q2 2021. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

Bollard Group reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 258 BioLife Solutions shares in Q3 2023, an estimated $6K.
Bollard Group first reported a position in BioLife Solutions in Q2 2020 and held it in 9 quarters.
Bollard Group's BioLife Solutions position peaked at $247K in Q2 2021.
153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.